Pelle Hanberg , Hans Christian Rasmussen , Mats Bue , Maiken Stilling , Andrea René Jørgensen , Elisabeth Krogsgaard Petersen , Johanne Gade Lilleøre , Magnus A. Hvistendahl , Jesper Bille , Tejs Ehlers Klug
{"title":"在猪模型中通过微透析测量肠内和静脉注射青霉素后口咽和额窦组织中的青霉素浓度。","authors":"Pelle Hanberg , Hans Christian Rasmussen , Mats Bue , Maiken Stilling , Andrea René Jørgensen , Elisabeth Krogsgaard Petersen , Johanne Gade Lilleøre , Magnus A. Hvistendahl , Jesper Bille , Tejs Ehlers Klug","doi":"10.1016/j.ejps.2024.106859","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Penicillin may be administered enterally or intravenously for the treatment of bacterial infections within the oropharynx and the frontal sinuses. We aimed to assess and compare penicillin concentrations in oropharyngeal and frontal sinus tissues following enteral and intravenous administration in a porcine model.</p></div><div><h3>Method</h3><p>Twelve pigs were randomized to receive either enteral (0.8 g Penicillin V) or intravenous (1.2 g Penicillin G) penicillin. Microdialysis was used for sampling in oropharyngeal and frontal sinus tissues during a six-hour dosing interval. In addition, plasma samples were collected. The primary endpoints were time with drug concentration above the minimal inhibitory concentration (<em>T</em>>MIC) for two MIC targets: 0.125 (low target) and 0.5 (high target) μg/mL (covering Group A Streptococci, <em>Fusobactarium necrophorum, Streptococcus pneumoniae</em> and <em>Hemophilus influenza</em>) and attainment of these treatment targets for ≥50 % <em>T</em>>MIC.</p></div><div><h3>Results</h3><p>For both the low and high MIC targets, intravenous administration resulted in higher <em>T</em>>MIC in oropharyngeal and frontal sinus tissues compared to enteral administration. In oropharyngeal tissue, the treatment target (≥50 % <em>T</em>>MIC) was achieved for both the low target (96 %) and high target (68 %) when penicillin was administrated intravenously. In frontal sinus tissue, the treatment target was reached for the low target (70 %), but not the high target (35 %) when administered intravenously. None of the two tissues reached the treatment targets when penicillin was administered enterally.</p></div><div><h3>Conclusion</h3><p>Intravenous administrated penicillin in standard dosage is superior to enteral administration of penicillin in standard dosage in achieving clinically important <em>T</em>>MIC as the majority of targets were achieved following intravenously administration, while none of the targets were achieved following enteral administration. These results support the general notion of higher tissue concentrations following intravenous compared to enteral administration.</p></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"201 ","pages":"Article 106859"},"PeriodicalIF":4.3000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0928098724001714/pdfft?md5=11df70d48a9acbcdcf55b536057e9ebd&pid=1-s2.0-S0928098724001714-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Penicillin concentrations in oropharyngeal and frontal sinus tissue following enteral and intravenous administration measured by microdialysis in a porcine model\",\"authors\":\"Pelle Hanberg , Hans Christian Rasmussen , Mats Bue , Maiken Stilling , Andrea René Jørgensen , Elisabeth Krogsgaard Petersen , Johanne Gade Lilleøre , Magnus A. Hvistendahl , Jesper Bille , Tejs Ehlers Klug\",\"doi\":\"10.1016/j.ejps.2024.106859\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Penicillin may be administered enterally or intravenously for the treatment of bacterial infections within the oropharynx and the frontal sinuses. We aimed to assess and compare penicillin concentrations in oropharyngeal and frontal sinus tissues following enteral and intravenous administration in a porcine model.</p></div><div><h3>Method</h3><p>Twelve pigs were randomized to receive either enteral (0.8 g Penicillin V) or intravenous (1.2 g Penicillin G) penicillin. Microdialysis was used for sampling in oropharyngeal and frontal sinus tissues during a six-hour dosing interval. In addition, plasma samples were collected. The primary endpoints were time with drug concentration above the minimal inhibitory concentration (<em>T</em>>MIC) for two MIC targets: 0.125 (low target) and 0.5 (high target) μg/mL (covering Group A Streptococci, <em>Fusobactarium necrophorum, Streptococcus pneumoniae</em> and <em>Hemophilus influenza</em>) and attainment of these treatment targets for ≥50 % <em>T</em>>MIC.</p></div><div><h3>Results</h3><p>For both the low and high MIC targets, intravenous administration resulted in higher <em>T</em>>MIC in oropharyngeal and frontal sinus tissues compared to enteral administration. In oropharyngeal tissue, the treatment target (≥50 % <em>T</em>>MIC) was achieved for both the low target (96 %) and high target (68 %) when penicillin was administrated intravenously. In frontal sinus tissue, the treatment target was reached for the low target (70 %), but not the high target (35 %) when administered intravenously. None of the two tissues reached the treatment targets when penicillin was administered enterally.</p></div><div><h3>Conclusion</h3><p>Intravenous administrated penicillin in standard dosage is superior to enteral administration of penicillin in standard dosage in achieving clinically important <em>T</em>>MIC as the majority of targets were achieved following intravenously administration, while none of the targets were achieved following enteral administration. These results support the general notion of higher tissue concentrations following intravenous compared to enteral administration.</p></div>\",\"PeriodicalId\":12018,\"journal\":{\"name\":\"European Journal of Pharmaceutical Sciences\",\"volume\":\"201 \",\"pages\":\"Article 106859\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0928098724001714/pdfft?md5=11df70d48a9acbcdcf55b536057e9ebd&pid=1-s2.0-S0928098724001714-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0928098724001714\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098724001714","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
背景:青霉素可经肠道或静脉注射用于治疗口咽部和额窦内的细菌感染。我们的目的是在猪模型中评估和比较肠道和静脉注射青霉素后口咽和额窦组织中的青霉素浓度:方法:12 头猪随机接受青霉素肠内注射(0.8 克青霉素 V)或静脉注射(1.2 克青霉素 G)。在六小时的给药间隔期间,采用微透析法对口咽和额窦组织进行采样。此外,还采集了血浆样本。主要终点是药物浓度高于两个 MIC 目标的最小抑制浓度(T>MIC)的时间:0.125(低目标值)和 0.5(高目标值)微克/毫升(涵盖 A 组链球菌、坏死镰刀菌、肺炎链球菌和流感嗜血杆菌),以及达到这些治疗目标值的时间,即≥50%T>MIC:结果:对于低和高 MIC 目标,与肠道给药相比,静脉给药在口咽和额窦组织中导致更高的 T>MIC。在口咽部组织中,静脉注射青霉素时,低目标值(96%)和高目标值(68%)都能达到治疗目标(T>MIC ≥50%)。在额窦组织中,静脉注射青霉素时,低靶点(70%)达到治疗目标,但高靶点(35%)未达到治疗目标。结论:结论:静脉注射标准剂量的青霉素比肠内注射标准剂量的青霉素在达到临床重要的 T>MIC 方面更有优势,因为静脉注射青霉素可达到大多数目标,而肠内注射青霉素则无法达到任何目标。这些结果支持了静脉给药比肠内给药的组织浓度更高这一普遍观点。
Penicillin concentrations in oropharyngeal and frontal sinus tissue following enteral and intravenous administration measured by microdialysis in a porcine model
Background
Penicillin may be administered enterally or intravenously for the treatment of bacterial infections within the oropharynx and the frontal sinuses. We aimed to assess and compare penicillin concentrations in oropharyngeal and frontal sinus tissues following enteral and intravenous administration in a porcine model.
Method
Twelve pigs were randomized to receive either enteral (0.8 g Penicillin V) or intravenous (1.2 g Penicillin G) penicillin. Microdialysis was used for sampling in oropharyngeal and frontal sinus tissues during a six-hour dosing interval. In addition, plasma samples were collected. The primary endpoints were time with drug concentration above the minimal inhibitory concentration (T>MIC) for two MIC targets: 0.125 (low target) and 0.5 (high target) μg/mL (covering Group A Streptococci, Fusobactarium necrophorum, Streptococcus pneumoniae and Hemophilus influenza) and attainment of these treatment targets for ≥50 % T>MIC.
Results
For both the low and high MIC targets, intravenous administration resulted in higher T>MIC in oropharyngeal and frontal sinus tissues compared to enteral administration. In oropharyngeal tissue, the treatment target (≥50 % T>MIC) was achieved for both the low target (96 %) and high target (68 %) when penicillin was administrated intravenously. In frontal sinus tissue, the treatment target was reached for the low target (70 %), but not the high target (35 %) when administered intravenously. None of the two tissues reached the treatment targets when penicillin was administered enterally.
Conclusion
Intravenous administrated penicillin in standard dosage is superior to enteral administration of penicillin in standard dosage in achieving clinically important T>MIC as the majority of targets were achieved following intravenously administration, while none of the targets were achieved following enteral administration. These results support the general notion of higher tissue concentrations following intravenous compared to enteral administration.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.